FDA approves extended-release injection for opioid use disorder
The U.S. Food and Drug Administration has approved Brixadi (buprenorphine) extended-release injection to treat moderate-to-severe opioid use disorder.
May 31, 2023
0
5
The U.S. Food and Drug Administration has approved Brixadi (buprenorphine) extended-release injection to treat moderate-to-severe opioid use disorder.
May 31, 2023
0
5
The U.S. Food and Drug Administration has approved Xacduro (sulbactam for injection; durlobactam for injection) as a new treatment for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused ...
May 31, 2023
0
22
Flow cytometry, a laser-based technique employed to detect and analyze the chemical and physical characteristics of cells or particles, is already widely used for the assessment of animal sperm integrity. It can be repurposed ...
May 17, 2023
0
51
Surgery to relieve leg pain and disability in some people with sciatica may be better than other non-surgical treatments, but the benefits are short-lived, lasting only up to 12 months, finds an analysis of the latest evidence ...
Apr 19, 2023
0
20
Intramuscular administration of tranexamic acid (TXA), a drug used to target severe bleeding after childbirth, is safe and quickly reaches therapeutic concentrations in pregnant women, according to a study involving researchers ...
Apr 5, 2023
0
30
The development of various hypoxia-activated prodrugs (HAPs) has made considerable advances in the last few decades; however, cancer therapy using HAPs is still hindered by problems such as poor therapeutic outcomes due to ...
Apr 4, 2023
0
2
Researchers found that a minimally invasive procedure combined with epidural steroid injection treatment led to superior pain reduction and disability improvement over one year in patients with sciatica. The results of the ...
Mar 28, 2023
0
9
It's a controversial notion, but couples undergoing fertility treatments may soon be able to select the sex of their baby—with an 80% chance of success, doctors say.
Mar 22, 2023
0
24
People with chronic hepatitis B virus (HBV) infection are at in increased risk for liver cancer, cirrhosis and are 70% to 85% more likely to die prematurely than the general population, according to the Atlanta-based Centers ...
Mar 16, 2023
0
24
Patients with pulmonary arterial hypertension (PAH), a severe, progressive condition that affects the heart and lungs, who were treated with the novel first-in-class medication sotatercept on top of existing therapy experienced ...
Mar 7, 2023
0
193